Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours ยท Estimated delivery Oct 28 - Nov 2
Expanding Pipeline The GLP-1 pipeline is rich with new indications for existing FDA approved drugs as well as new market entrants
Weight Loss One study found that after one year, participants with type 1 diabetes who took an SGLT-2 inhibitor had an average weight loss of 4.4 percent
Ianalumabs Phase III trials showed a significant reduction in disease activity with a favorable safety profile, and an approval is likely in 2026
Combination therapy is always more effective, however with increased efficacy comes increased skin irritation
US$ 27.93
US$ 29.24
US$ 27.58
US$ 26.32
US$ 22.41
US$ 21.70
US$ 24.89
US$ 21.14
US$ 22.92
US$ 28.10
US$ 24.04
